Trial of Donanemab in Early Symptomatic Alzheimer Disease
This randomized clinical trial examines the efficacy and adverse effects of donanemab, a monoclonal antibody designed to clear brain amyloid plaque, among patients with early symptomatic Alzheimer...
jamanetwork.com